Showing results (1801-1810 of 1,847) with videos related to
Sort By:
Pageof 185
Biorxiv : the Preprint Server for Biology|September 26, 2025
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic CancerAlica K Beutel, Sabrina Calderon, Ethan Nghiem, et al.Scientific Reports|May 19, 2018
Origin of magnetic properties in carbon implanted ZnO nanowiresY F Wang, Y C Shao, S H Hsieh, et al.Nature Communications|October 31, 2024
Risk-stratified treatment for drug-susceptible pulmonary tuberculosisVincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, et al.Genome Medicine|April 30, 2017
Lost in translation: returning germline genetic results in genome-scale cancer researchAmber L Johns, Skye H McKay, Jeremy L Humphris, et al.Journal of the American Academy of Dermatology|July 21, 2001
A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acneJ S Strauss, J J Leyden, A W Lucky, et al.Cancer Cell|June 7, 2016
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal AdenocarcinomaColin W Steele, Saadia A Karim, Joshua D G Leach, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2015
Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) TrialLorraine A Chantrill, Adnan M Nagrial, Clare Watson, et al.Journal of the American Academy of Dermatology|July 21, 2001
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoinJ S Strauss, J J Leyden, A W Lucky, et al.Proceedings of the National Academy of Sciences of the United States of America|March 11, 2022
Engineered nanoparticles enable deep proteomics studies at scale by leveraging tunable nano-bio interactionsShadi Ferdosi, Behzad Tangeysh, Tristan R Brown, et al.Genome Medicine|September 6, 2013
Clinical and molecular characterization of HER2 amplified-pancreatic cancerAngela Chou, Nicola Waddell, Mark J Cowley, et al.Pageof 185